Ashraf Brik
- Molecular Biology top 0.5%
- Organic Chemistry top 0.2%
- Oncology top 1%
- Infectious Diseases top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Co-authors
- Muhammad JbaraK. S. Ajish KumarChi‐Huey WongMahmood Haj‐YahyaLiat SpasserSuman Kumar MaityPeter SimanSudhir N. Bavikar
- Topics
- Ubiquitin and proteasome pathways (79 papers)Chemical Synthesis and Analysis (67 papers)Click Chemistry and Applications (64 papers)
- Partner nations
- IsraelUnited StatesJapan
In The Last Decade
Ashraf Brik
179 papers receiving 8.8k citations
Peers
Comparison fields: 5 of 127
- Molecular Biology 7.4k
- Organic Chemistry 4.3k
- Oncology 2.1k
- Infectious Diseases 548
- Radiology, Nuclear Medicine and Imaging 542
Countries citing papers authored by Ashraf Brik
This map shows the geographic impact of Ashraf Brik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf Brik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf Brik more than expected).
Fields of papers citing papers by Ashraf Brik
This network shows the impact of papers produced by Ashraf Brik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf Brik. The network helps show where Ashraf Brik may publish in the future.
Co-authorship network of co-authors of Ashraf Brik
This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf Brik. A scholar is included among the top collaborators of Ashraf Brik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf Brik. Ashraf Brik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 33 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 94 | |
| 8 | 17 | |
| 9 | 22 | |
| 10 | 69 | |
| 11 | 130 | |
| 12 | 27 | |
| 13 | 117 | |
| 14 | Novel chemical tools to facilitate the synthesis and control the folding and Self-assembly of amyloid-forming polypeptides | 1 |
| 15 | 72 | |
| 16 | 111 | |
| 17 | Extended Sugar-Assisted Ligations: Development, Scope and Applications | 1 |
| 18 | 36 | |
| 19 | 133 | |
| 20 | 10 |
About Ashraf Brik
Ashraf Brik is a scholar working on Organic Chemistry, Molecular Biology and Oncology, having authored 182 papers that have together received 9.0k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (79 papers), Chemical Synthesis and Analysis (67 papers) and Click Chemistry and Applications (64 papers). The work is most often cited by research in Organic Chemistry (4.3k citations), Molecular Biology (7.4k citations) and Oncology (2.1k citations). Ashraf Brik has collaborated with scholars based in Israel, United States and Japan. Frequent co-authors include Muhammad Jbara, K. S. Ajish Kumar, Chi‐Huey Wong, Mahmood Haj‐Yahya, Chi‐Huey Wong, Liat Spasser, Suman Kumar Maity, Peter Siman, Sudhir N. Bavikar and Somasekhar Bondalapati. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.